Head-to-head · Cost-Efficiency Index
REMEVi vs Totara Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.
Visit REMEViTotara Health
Shoppers who want a flat month-to-month GLP-1 price that doesn't climb with the dose, and the option of a tablet or drops instead of a shot.
Visit Totara HealthThe verdict
REMEVi and Totara Health tie on the Cost-Efficiency Index at 80/100, so neither wins outright on the numbers, so choose on fit. REMEVi: Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language. Totara Health: Shoppers who want a flat month-to-month GLP-1 price that doesn't climb with the dose, and the option of a tablet or drops instead of a shot.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | Totara Health |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 80/100 |
| Semaglutide / mo | $219/mo | $190/mo1-month plan, same price at every dose, compounded |
| Tirzepatide / mo | $319/mo | $239/mo1-month plan, same price at every dose, compounded |
| Semaglutide / yr (modeled) | $2,628 | $2,280 |
| Tirzepatide / yr (modeled) | $3,828 | $2,868 |
| Coverage | All 50 states | 48 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #34 | #36 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Totara Health
80/100Where the value is
- One-month plans are priced on the product page before any intake: $190 for semaglutide and $239 for tirzepatide, the same at every dose
- Semaglutide comes as an injection, oral drops or an under-the-tongue tablet; tirzepatide as an injection or under-the-tongue tablet
- Names its dispensing pharmacy (Manifest Pharmacy in Greer, South Carolina) and its clinician network (MD Integrations)
The tradeoffs
- The lower monthly figures ($133, $119 and $99 for semaglutide) require a 3-, 6- or 12-month plan paid in one charge up front
- The banner says all 50 states, but the FAQ's state list leaves out Alaska and Mississippi
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.